These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 651930)

  • 1. [Rifampicin-induced hepatitis in childhood].
    Bedir O; Yalcin E; Eskinasis N
    Monatsschr Kinderheilkd (1902); 1978 May; 126(5):337-9. PubMed ID: 651930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Jaundice and rifampicin. Critical study].
    Nebout T; Dhumeaux D; Berthelot P
    Nouv Presse Med; 1974 Mar; 3(12):733-6. PubMed ID: 4836507
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatotoxicity of rifampicin-rifamycin SV in the treatment of tuberculous meningitis (author's transl)].
    Ziebart-Schroth A
    Wien Klin Wochenschr; 1973 Oct; 85(42):692-5. PubMed ID: 4128922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
    Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
    Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
    Kuntz HD; Rausch V; Bammel E
    Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
    Kameda K; Kawabata S; Shirai S
    Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
    Abeledo Mezquita G; Otero Reigada MC
    An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. 2. Drug resistance, drug concentration in blood and side effects].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Dec; 46(12):481-9. PubMed ID: 5004601
    [No Abstract]   [Full Text] [Related]  

  • 15. More adverse reactions to rifampicin.
    Gutman L
    J Antimicrob Chemother; 1978 May; 4(3):283. PubMed ID: 670121
    [No Abstract]   [Full Text] [Related]  

  • 16. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of allergic drug-induced hepatitis suspected with rifampicin-induced antinuclear antibody].
    Matsui S; Nakazawa T; Dobashi K; Mori M
    Arerugi; 1994 Oct; 43(10):1280-2. PubMed ID: 7826225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our experience with Rifampicin].
    Kramer R; Simon K
    Prax Pneumol; 1971 Oct; 25(10):610-4. PubMed ID: 5137081
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy.
    Ji BH; Chen JK; Wang CM; Xia GA
    Lepr Rev; 1984 Sep; 55(3):283-9. PubMed ID: 6492989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.